4
Changes in Ownership
HANOVER INSURANCE GROUP, INC. Filed Acc 0001062993-25-006637
President and CEO sold 701 shares at an average $175.02 ($122,687)
- President and CEO acquired 701 shares (option exercise)
- President and CEO acquired 135.86 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Roche John C President and CEO | 2025-03-28 | Option exercise 10b5-1 | +400 | $77.91 | $31,164 | 124,677.85 | D: show line 1 in the form |
| Roche John C President and CEO | 2025-03-28 | Sale 10b5-1 | −400 | $175.03 | $70,012 | 124,277.85 | D: show line 2 in the form |
| Roche John C President and CEO | 2025-03-28 | Grant or award 10b5-1 | +135.86 | 124,413.71 | D: show line 3 in the form | ||
| Roche John C President and CEO | 2025-03-31 | Option exercise 10b5-1 | +301 | $77.91 | $23,451 | 124,714.71 | D: show line 4 in the form |
| Roche John C President and CEO | 2025-03-31 | Sale 10b5-1 | −301 | $175.00 | $52,675 | 124,413.71 | D: show line 5 in the form |
| Open-market sales · 701 sh · avg $175.02 · $122,687 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Roche John C President and CEO | 2025-03-28 | Option exercise · Common Stock Option (right to buy) 10b5-1 | −400 | 9,207 | D: show line 6 in the form | ||
| Roche John C President and CEO | 2025-03-31 | Option exercise · Common Stock Option (right to buy) 10b5-1 | −301 | 8,906 | D: show line 7 in the form |
Loading xslF345X05/form4.xml…